Pharming Group's market cap is currently $1.16B. The company's EPS TTM is $0.01; its P/E ratio is 1,133.33; Pharming Group is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is lt;0.01. See an overview of income statement, balance sheet, and cash flow financials.
